Clinical Trials Browser

Phase 2 × rovalpituzumab tesirine × Tumor-Agnostic × Clear all

NCT03543358 2021-01-05

A Long-Term Study of Rovalpituzumab Tesirine

Phase 2 Completed

3 enrolled 6 charts

Neoplasms